Trial Profile
Reducing light sensitivity after photodynamic therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2016
Price :
$35
*
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Skin disorders
- Focus Adverse reactions
- 14 Dec 2016 New trial record